Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
4.500
+0.380 (9.22%)
At close: Feb 21, 2025, 4:00 PM
4.190
-0.310 (-6.89%)
After-hours: Feb 21, 2025, 6:06 PM EST
RGC Market Cap
RGC has a market cap or net worth of $58.56 million as of February 21, 2025. Its market cap has decreased by -60.87% in one year.
Market Cap
58.56M
Enterprise Value
50.68M
1-Year Change
-60.87%
Ranking
Category
Stock Price
$4.50
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has decreased from $120.10M to $58.56M, a decrease of -51.24%. That is a compound annual growth rate of -18.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 58.56M | -8.91% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.64M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |